Antibodies are immune system proteins that recognize noxious molecules for elimination. 13
Introduction 26 27
Antibodies (or B-cell receptors) are protein products of B-cells and primary actors of adaptive immunity 28 in jawed vertebrates (1). They are highly malleable molecules that can bind to virtually any antigen. An 29 organism holds a great variety of these molecules increasing the probability that an arbitrary antigen 30 can be recognized by an antibody, initiating an immune response (2). Owing to their binding malleability 31 they are the most prominent class of reagents and biotherapeutics (3, 4) . Continued successful exploitation of these molecules relies on our ability to discern the functional diversity of antibody data to perform standardized sequencing analyses. Ultimately, because immunoinformatics is not the 65 chief focus of such services, bulk data download from such websites is limited and converting the raw 66 nucleotide data obtained into a format suitable for analysis still requires non-trivial effort.
68
To address these issues, we have created the Observed Antibody Space (OAS) resource that allows large-69 scale data mining of antibody repertoires. We have so far collected the raw outputs of 53 Ig-seq 70 experiments covering over half a billion sequences. We have organized the sequences by metadata such 71 as organism, isotype, B-cell type and source, and the immune status of B-cell donors to facilitate bulk 72 retrieval of specific subsets for comparative analyses. We have converted all of the Ig-seq sequences to 73 amino acids and numbered them using the IMGT scheme. The data is available for querying or bulk 74 download at http://antibodymap.org. We believe that OAS will facilitate data mining antibody 75 repertoires for improved understanding of the dynamics of the immune system and thus better 76 engineering of biotherapeutics. 77 78
Materials and Methods 79 80
A list of study accession codes of publically available Ig-seq datasets were obtained via a literature 81 review. The majority of raw reads were downloaded from the European Nucleotide Archive (ENA) (29) 82 and the National Center for Biotechnology Information (NCBI) websites (30). In a small number of cases, 83 another public Ig-seq repository was specified e.g. (14, (31) (32) (33) . Metadata were manually extracted from 84 the deposited datasets and arranged in a reproducible format.
86
The downloaded FASTQ files were processed depending on the sequencing platform. Paired raw 87 Illumina reads were assembled with FLASH (34). The assembled antibody sequences were converted to 88 the FASTA format using FASTX-toolkit (35) . As raw reads from Roche 454 are not paired, these FASTQ 89 files were directly converted to the FASTA format with the FASTX-toolkit.
91
The heavy chain sequences were automatically annotated with isotype information unless such data was 92 given in the corresponding publication. Automatic isotype annotation was performed by aligning the 93 constant heavy domain 1 (CH1) of any given antibody sequence against the IMGT isotype reference (36) 94 of the respective species using the Smith-Waterman algorithm (37). We assigned a score of two for a 95 nucleotide match, and a score of minus one for a nucleotide mismatch or a gap. The IMGT isotype references comprised 21 nucleotide-long fragments of the CH1 domain of the antibody isotypes. To ensure a high confidence of correct isotype identification, we employed a conservative threshold of 30 98 in the Smith-Waterman algorithm scoring function. Sequences whose Smith-Waterman algorithm score 99 was below the threshold for all isotypes were assigned as 'bulk'. The robustness of this protocol was
The numbered amino acid sequences in each dataset are sorted by metadata e.g. individuals, age, 140 vaccination regime, B-cell type and source etc. (Figure 1 ). Deposition of such metadata is currently not 141 standardized and requires ad hoc manual curation for each dataset. In an effort to organize the antibody 142 sequences using such metadata, we have grouped the sequences within each dataset into Data Units.
143
Each Data Unit represents a group of sequences within a given dataset with a unique combination of 144 metadata values. The metadata values are summarized in Table 1 
239
Beyond identifying broad commonalities across repertoires, data mining Ig-seq outputs provides novel avenues for designing better antibody-based therapeutics. The plethora of currently available Ig-seq 242 data offers a glimpse at a set of sequences that should be able to fold and function in an organism.
243
Aligning therapeutic candidates to sequences in Ig-seq repertoires can reveal mutational choices that 244 might be naturally acceptable hence providing shortcuts for antibody engineering such as humanization 245 (89) . Furthermore, contrasting the naturally observed antibodies with therapeutic ones can offer insight 246 as to the naturally favored biophysical properties of these molecules (4). All such future applications rely 247 on the availability of well-structured datasets that can offer a unified point of reference for 248 bioinformatics analyses. We hope that OAS will aid data mining antibody repertoires, help identify 249 strategic preferences of our immune systems and will ultimately improve how we engineer antibodies 250 into better therapeutics.
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